Moncas (Montelukast)

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, stopping leukotrienes from causing bronchoconstriction, mucus production, and inflammation in the airways. This receptor antagonism helps keep the airways open and reduces allergic symptoms.

The appropriate dose of Moncas is determined by the prescribing healthcare professional based on the patient’s age, weight, and specific condition. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for montelukast in pregnancy and lactation are limited. Healthcare providers weigh potential benefits against possible risks before prescribing it to pregnant or nursing individuals. Patients should discuss their situation with a qualified clinician.

To request Moncas, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moncas (montelukast) belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients who need an add‑on therapy or have difficulty using inhalers, though it does not replace rescue bronchodilators for acute attacks.

Moncas should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, heat and direct sunlight to maintain stability and potency throughout its shelf life.

Moncas is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include rare neuropsychiatric events such as mood changes, depression, or suicidal thoughts, as well as severe allergic reactions like angioedema, Stevens‑Johnson syndrome, and hepatic injury. Any concerning symptoms should prompt immediate medical attention.

Moncas is contraindicated in individuals with known hypersensitivity to montelukast or any component of the formulation. It should not be used as a rescue medication for sudden asthma attacks, and patients with severe liver disease should consult their physician before use.